Side Effects of Weight Loss Injection Drugs: What the Evidence Shows

What clinical trials found about how often side effects occur

The trial evidence is reassuring in one sense and honest in another. In SURMOUNT-1, the largest phase-three study of tirzepatide for weight management, gastrointestinal events were the most frequently reported adverse effects, nausea, diarrhoea, vomiting, constipation and indigestion each appeared more often in the active groups than in the placebo group, and most were rated mild to moderate in severity. Discontinuation due to side effects occurred in roughly 4–7% of participants at higher doses, which the researchers considered consistent with other medicines in this class. The SURMOUNT-1 paper published in the New England Journal of Medicine provides the detailed breakdown for anyone who wants to read the primary data. For semaglutide, the STEP 1 trial reported a broadly similar profile: nausea was the most common complaint, peaking early and then declining as the body adjusted to the medicine.

The pattern that emerges across both medicines is timing. Side effects cluster around two moments: the beginning of treatment, and the days following a dose increase. Between those points, many people report little or no ongoing discomfort. That does not mean everyone sails through (individual responses vary considerably) but it does mean that early nausea is not necessarily a signal that treatment will always feel this way.

Eating smaller meals, staying well hydrated and avoiding fatty or highly processed foods during the first weeks are commonly cited strategies. Personal dietary adjustments should be discussed with your prescriber rather than improvised.

The side effects that turn up most commonly, and what they feel like in practice

A question our prescribers hear most weeks is some version of: 'Will I feel sick the whole time?' The honest answer is that nausea is common, especially at the start, but persistent severe nausea is not the norm. The NHS patient information for tirzepatide lists the following as common (meaning they may affect more than one in a hundred people): nausea, vomiting, diarrhoea, constipation, stomach pain, indigestion, burping, fatigue, dizziness, headache, and reactions at the injection site such as redness or mild discomfort.

Injection-site reactions (small areas of redness, itching or bruising where the pen was used) are generally mild and resolve quickly. Rotating injection sites (abdomen, thigh, and upper arm are all licensed locations) reduces their frequency. For more on the practical side of using the pen, the weight loss injection overview covers technique basics.

Less commonly, some people notice hair thinning in the months after significant weight loss. This is thought to reflect the physical stress of rapid body-weight change rather than a direct drug effect, and it typically resolves. It is worth raising with your prescriber if it concerns you.

If you are weighing up Wegovy against Mounjaro, our page on the side effects of injectable weight loss drugs sets out how the two medicines compare, which can be a useful reference before a clinical assessment. The choice between them is rarely made on tolerability grounds alone, eligibility, clinical history and individual response all shape that decision, and it is one made during a clinical assessment, not before it.

When to get medical help: the symptoms that need prompt attention

Most side effects from weight loss injection drugs are unpleasant rather than dangerous. A handful are not. Knowing the difference could matter.

In January 2026, the MHRA published a Drug Safety Update for GLP-1 receptor agonist medicines that highlighted acute pancreatitis as a known but infrequent risk that can be serious. The symptom to recognise is severe, persistent abdominal pain (often described as boring through to the back) that may come with vomiting and does not settle. If that describes what you are experiencing, seek urgent medical care and tell the clinician which medicine you are taking.

Other situations that warrant prompt attention include: signs of a serious allergic reaction (swelling of the face, throat or tongue, difficulty breathing, rapid heartbeat); symptoms of severe dehydration from prolonged vomiting or diarrhoea (confusion, very dark urine, inability to keep fluids down); and gallbladder symptoms such as sudden severe pain in the upper right abdomen, especially after eating. Rapid or unexplained changes in vision should also be reviewed, this is particularly relevant for people who have diabetes alongside obesity.

For a fuller list of serious and rare adverse effects, the page on bad side effects of weight loss injections goes into more detail. Our guide to the side effects of weight loss injections is also worth reading if you want a broader overview of what to monitor throughout treatment, not just at the acute end of the spectrum. Side effects can also be reported directly to the MHRA via the Yellow Card scheme, this applies to suspected side effects from any medicine, and the reports genuinely inform ongoing safety monitoring.

How side effects are managed in supervised treatment

Supervision changes the side-effect experience significantly. When a prescriber reviews your case before every repeat, there is a natural checkpoint: how has treatment been? Any new symptoms? Is the current dose still appropriate? That is very different from adjusting a dose alone based on a forum post.

Titration (starting at the lowest dose and increasing gradually) exists precisely to reduce side-effect burden. The starting dose of tirzepatide, for instance, is lower than any therapeutic target; its job is to give the body time to adapt before the dose climbs. People who try to move through doses faster than the schedule allows tend to experience more nausea, not less. A prescriber holds that pace.

At nume, every repeat order is clinically re-reviewed before it is dispensed. This is not a formality. It is the point at which side-effect patterns are caught, doses are adjusted, and (where needed) treatment is paused. If you have questions about how that process works or want to understand what a consultation covers, our FAQs page answers the most common queries. For a broader look at the effects of weight loss injections beyond the side-effect profile, that page sets out both what these medicines do and what they do not do. Our clinical team oversees prescribing across all treatments we dispense.

If you are ready to have a proper clinical conversation about whether injection treatment is suitable for you, and what to expect from it, start your free consultation with our prescribers. There is no obligation, and suitability is always assessed individually.